33 daysTime to First Decision

Lymphatics, Volume 2, Issue 3

September 2024 - 5 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

Select all

Article

1 Citations

5,334 Views

18 Pages

Characterization of Photo-Crosslinked Methacrylated Type I Collagen as a Platform to Investigate the Lymphatic Endothelial Cell Response

Brian N. K. Ruliffson,
Stephen M. Larson,
Eleni K. Xhupi,
Diana L. Herrera-Diaz and
Catherine F. Whittington

Lymphatics2024, 2(3), 177-194;https://doi.org/10.3390/lymphatics2030015

19 September 2024

Despite chronic fibrosis occurring in many pathological conditions, few in vitro studies examine how fibrosis impacts lymphatic endothelial cell (LEC) behavior. This study examined stiffening profiles of PhotoCol®—commercially available met...

Full Article

Article

3,928 Views

9 Pages

T-Cells Rich Classical Hodgkin Lymphoma, a Pathology Diagnostic Pitfall for Nodular Lymphocyte-Predominant Hodgkin Lymphoma; Case Series and Review

Haneen Al-Maghrabi,
Ghadeer Mokhtar and
Ahmed Noorsaeed

Lymphatics2024, 2(3), 168-176;https://doi.org/10.3390/lymphatics2030014

12 September 2024

Background: Some cases of classic Hodgkin lymphoma (CHL) display similarities to nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) in terms of architecture, leading to potential challenges in diagnosis. However, these difficulties can be overco...

Full Article

Article

1,345 Views

11 Pages

MicroRNA: A Signature for the Clinical Progression of Chronic Lymphocytic Leukemia

Yuliya A. Veryaskina,
Sergei E. Titov,
Igor B. Kovynev,
Tatiana I. Pospelova,
Sofya S. Fyodorova,
Yana Yu. Shebunyaeva,
Sergei A. Demakov,
Pavel S. Demenkov and
Igor F. Zhimulev

Lymphatics2024, 2(3), 157-167;https://doi.org/10.3390/lymphatics2030013

13 August 2024

Chronic lymphocytic leukemia (CLL) is the most common human leukemia. The disease is caused by abnormal proliferation and development of lymphocytes and their precursors in the blood and bone marrow (BM). Recent studies have shown that the CLL’...

Full Article

Commentary

2,295 Views

10 Pages

Persistent B-Cell Stimulation or B-Cell Repertoire Anomalies? The Dilemma of the Origin of Chronic Lymphocytic Leukemia (CLL)

Manlio Ferrarini,
Davide Bagnara,
Fabio Ghiotto and
Franco Fais

Lymphatics2024, 2(3), 147-156;https://doi.org/10.3390/lymphatics2030012

7 August 2024

Chronic Lymphocytic Leukemia (CLL) is caused by the clonal expansion of CD5+ B lymphocytes in the circulation, peripheral lymphoid organs and bone marrow [...]

Full Article

Article

2,923 Views

14 Pages

Prevalence and Quality of Life in Patients with Lymphoedema following Axillary Clearance for Breast and Cutaneous Malignancies

Tae Hyun Kim,
Sarah R. Adamson,
Pelicia Lim,
Kevin Tran,
Kevin Nguyen,
Derek Neoh,
Su Wen Loh and
Sally Ng

Lymphatics2024, 2(3), 133-146;https://doi.org/10.3390/lymphatics2030011

13 July 2024

Lymphoedema is a potential adversity following axillary clearance, which is frequently performed in the setting of surgery for breast cancer or cutaneous malignancies of the upper limb. Often underestimated, lymphoedema can lead to debilitating sympt...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Lymphatics - ISSN 2813-3307|Creative Common CC BY license

Imprint

Download Flyer